Regulatory Approval

GuideAI Health's new AI platform just hit the public market. It promises to find hidden vascular disease in routine scans, but can it navigate the risks?

Binance's landmark offering of SpaceX shares in ADGM isn't just about access; it's a blueprint for the future of regulated digital asset markets.

With FDA clearance and strategic provincial funding, Conavi Medical's dual-imaging system isn't just a new device; it's a new playbook for medtech.

With a new FDA Fast Track designation, Satellos Bioscience aims to accelerate its unique muscle-regenerating drug for Duchenne, a strategy that could sidestep genetic limitations.

Merck's new HIV drug, IDVYNSO™, gets a crucial boost via a public health deal, signaling a strategic play to reclaim ground in a multi-billion dollar market.

Bullish secures key approval in Gibraltar for tokenized securities, a strategic move paired with its Equiniti acquisition to build a regulated, end-to-end digital asset ecosystem.

Larimar Therapeutics is rewriting the rare disease playbook. Its BLA filing for nomlabofusp leverages a novel FDA-aligned endpoint, creating a de-risked path to market.

Viridian's Lumvoa gains FDA approval for Thyroid Eye Disease, challenging a blockbuster drug and validating DRI Healthcare's unique royalty investment model.

For over a million Europeans with Parkinson's, a new drug promises longer periods of symptom control. But the path from regulatory approval to patient is complex.

A newly approved Swedish mine could break Europe's reliance on China for critical minerals, but it sits on the edge of a vital lake, pitting strategic need against local fears.

A rare disease drug's EU approval is revoked over 'misleading' data, impacting patients and signaling a new era of strict regulatory scrutiny for pharma giants.

Ottawa approves a key road to the Ring of Fire, balancing Indigenous-led growth against deep environmental and inter-community rifts. What does this signal?

Nemaska Lithium plans a major expansion of its Whabouchi mine, testing Canada's regulations and pitting the global hunger for EV minerals against local concerns.

A new DARPA-backed technology from ARA uses biological principles to create life-saving medicines on-demand, bypassing fragile supply chains for the military.

A new program gives Georgia's largest companies direct control over their green energy sourcing. Is this a model for the future or a subsidy in disguise?

As crypto markets fragment, WhiteBIT's new 'Crypto Bundles' offer simplified, index-style investing. But do these thematic baskets truly tame risk?

After an eight-year, community-led process, Webequie First Nation has secured approval for a supply road, setting a new precedent for self-determination.

At the University of Miami, 3D anatomical avatars are changing doctor visits. This tech promises clarity, but what are the hidden costs of progress?

NANO Nuclear's microreactor project enters formal NRC review, a pivotal step toward on-campus deployment and a new era of decentralized, clean nuclear power.